The present study demonstrated that low-dosage aspirin (0.1–0.5 mM) did not inhibit the proliferation of HCC cells; however, it did inhibit the invasiveness of HCC cells with lower expression of HTATIP2, which is a known tumor suppressor gene [21], [22], [40]. Here, HTATIP2 is linked to hepatocellular carcinoma.